ADAP2 drives immune-associated progression of esophageal cancer and serves as a potential therapeutic target
Author:
Xiangkun Du,Heshan Chen,Rongyu Xu,Shaogeng Chen,Jingliang Fu,Rongqi He
Publication:
Pathology - Research and Practice
© 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.